The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cold and Flu Drugs Market Research Report 2024
Synopsis
Cold medicines are medications used by people with the common cold, cough, or related conditions. There is, however, no good evidence that cough medications reduce coughing.
The global Cold and Flu Drugs market was valued at US$ 40130 million in 2023 and is anticipated to reach US$ 58780 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The Cough and Cold Remedies Market is driven by the recurring nature of respiratory ailments and seasonal illnesses, such as coughs and colds, which create a consistent demand for over-the-counter remedies. Cough and cold remedies, including cough syrups, decongestants, and throat lozenges, provide individuals with relief from common symptoms and discomfort associated with these ailments. As consumers prioritize self-care and symptom management, the market for these remedies continues to expand. The advent of innovative formulations and delivery methods further fuels market growth. However, a significant challenge for this market is the need to address regulatory and safety concerns surrounding certain ingredients, ensuring that remedies are effective and safe for users. Overcoming the evolving landscape of cold and flu viruses and the need to tailor products to address specific symptoms pose ongoing challenges. Additionally, the market faces competition from alternative therapies, natural remedies, and preventive measures. Striking a balance between providing accessible and reliable remedies for symptom relief while navigating evolving consumer preferences and safety considerations is crucial for the continued growth of the Cough and Cold Remedies Market.
This report aims to provide a comprehensive presentation of the global market for Cold and Flu Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold and Flu Drugs.
Report Scope
The Cold and Flu Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cold and Flu Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cold and Flu Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Reckitt Benckiser Group
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands Holdings
Procter & Gamble
Segment by Type
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others
Segment by Application
OTC
Rx
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cold and Flu Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cold medicines are medications used by people with the common cold, cough, or related conditions. There is, however, no good evidence that cough medications reduce coughing.
The global Cold and Flu Drugs market was valued at US$ 40130 million in 2023 and is anticipated to reach US$ 58780 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The Cough and Cold Remedies Market is driven by the recurring nature of respiratory ailments and seasonal illnesses, such as coughs and colds, which create a consistent demand for over-the-counter remedies. Cough and cold remedies, including cough syrups, decongestants, and throat lozenges, provide individuals with relief from common symptoms and discomfort associated with these ailments. As consumers prioritize self-care and symptom management, the market for these remedies continues to expand. The advent of innovative formulations and delivery methods further fuels market growth. However, a significant challenge for this market is the need to address regulatory and safety concerns surrounding certain ingredients, ensuring that remedies are effective and safe for users. Overcoming the evolving landscape of cold and flu viruses and the need to tailor products to address specific symptoms pose ongoing challenges. Additionally, the market faces competition from alternative therapies, natural remedies, and preventive measures. Striking a balance between providing accessible and reliable remedies for symptom relief while navigating evolving consumer preferences and safety considerations is crucial for the continued growth of the Cough and Cold Remedies Market.
This report aims to provide a comprehensive presentation of the global market for Cold and Flu Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold and Flu Drugs.
Report Scope
The Cold and Flu Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cold and Flu Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cold and Flu Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Reckitt Benckiser Group
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands Holdings
Procter & Gamble
Segment by Type
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others
Segment by Application
OTC
Rx
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cold and Flu Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cold and Flu Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antihistamines
1.2.3 Expectorants
1.2.4 Bronchodilators
1.2.5 Decongestants
1.2.6 Antibiotics
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cold and Flu Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 OTC
1.3.3 Rx
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cold and Flu Drugs Market Perspective (2019-2030)
2.2 Cold and Flu Drugs Growth Trends by Region
2.2.1 Global Cold and Flu Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cold and Flu Drugs Historic Market Size by Region (2019-2024)
2.2.3 Cold and Flu Drugs Forecasted Market Size by Region (2025-2030)
2.3 Cold and Flu Drugs Market Dynamics
2.3.1 Cold and Flu Drugs Industry Trends
2.3.2 Cold and Flu Drugs Market Drivers
2.3.3 Cold and Flu Drugs Market Challenges
2.3.4 Cold and Flu Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold and Flu Drugs Players by Revenue
3.1.1 Global Top Cold and Flu Drugs Players by Revenue (2019-2024)
3.1.2 Global Cold and Flu Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Cold and Flu Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cold and Flu Drugs Revenue
3.4 Global Cold and Flu Drugs Market Concentration Ratio
3.4.1 Global Cold and Flu Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold and Flu Drugs Revenue in 2023
3.5 Cold and Flu Drugs Key Players Head office and Area Served
3.6 Key Players Cold and Flu Drugs Product Solution and Service
3.7 Date of Enter into Cold and Flu Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cold and Flu Drugs Breakdown Data by Type
4.1 Global Cold and Flu Drugs Historic Market Size by Type (2019-2024)
4.2 Global Cold and Flu Drugs Forecasted Market Size by Type (2025-2030)
5 Cold and Flu Drugs Breakdown Data by Application
5.1 Global Cold and Flu Drugs Historic Market Size by Application (2019-2024)
5.2 Global Cold and Flu Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cold and Flu Drugs Market Size (2019-2030)
6.2 North America Cold and Flu Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cold and Flu Drugs Market Size by Country (2019-2024)
6.4 North America Cold and Flu Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cold and Flu Drugs Market Size (2019-2030)
7.2 Europe Cold and Flu Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cold and Flu Drugs Market Size by Country (2019-2024)
7.4 Europe Cold and Flu Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cold and Flu Drugs Market Size (2019-2030)
8.2 Asia-Pacific Cold and Flu Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cold and Flu Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Cold and Flu Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cold and Flu Drugs Market Size (2019-2030)
9.2 Latin America Cold and Flu Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cold and Flu Drugs Market Size by Country (2019-2024)
9.4 Latin America Cold and Flu Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold and Flu Drugs Market Size (2019-2030)
10.2 Middle East & Africa Cold and Flu Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cold and Flu Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Cold and Flu Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Reckitt Benckiser Group
11.1.1 Reckitt Benckiser Group Company Detail
11.1.2 Reckitt Benckiser Group Business Overview
11.1.3 Reckitt Benckiser Group Cold and Flu Drugs Introduction
11.1.4 Reckitt Benckiser Group Revenue in Cold and Flu Drugs Business (2019-2024)
11.1.5 Reckitt Benckiser Group Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Cold and Flu Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Cold and Flu Drugs Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Cold and Flu Drugs Introduction
11.3.4 GlaxoSmithKline Revenue in Cold and Flu Drugs Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Cold and Flu Drugs Introduction
11.4.4 Novartis Revenue in Cold and Flu Drugs Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Cold and Flu Drugs Introduction
11.5.4 Bayer Revenue in Cold and Flu Drugs Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Cold and Flu Drugs Introduction
11.6.4 AstraZeneca Revenue in Cold and Flu Drugs Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Detail
11.7.2 Sun Pharmaceutical Industries Business Overview
11.7.3 Sun Pharmaceutical Industries Cold and Flu Drugs Introduction
11.7.4 Sun Pharmaceutical Industries Revenue in Cold and Flu Drugs Business (2019-2024)
11.7.5 Sun Pharmaceutical Industries Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Cold and Flu Drugs Introduction
11.8.4 Pfizer Revenue in Cold and Flu Drugs Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Prestige Brands Holdings
11.9.1 Prestige Brands Holdings Company Detail
11.9.2 Prestige Brands Holdings Business Overview
11.9.3 Prestige Brands Holdings Cold and Flu Drugs Introduction
11.9.4 Prestige Brands Holdings Revenue in Cold and Flu Drugs Business (2019-2024)
11.9.5 Prestige Brands Holdings Recent Development
11.10 Procter & Gamble
11.10.1 Procter & Gamble Company Detail
11.10.2 Procter & Gamble Business Overview
11.10.3 Procter & Gamble Cold and Flu Drugs Introduction
11.10.4 Procter & Gamble Revenue in Cold and Flu Drugs Business (2019-2024)
11.10.5 Procter & Gamble Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
